RxDoctor Payments Data

Sara Federico

Pediatric Hematology-Oncology · Memphis, TNNPI 1275655466

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (58.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 3 manufacturers reported payments, led by USWM, LLC at 58.1% of the total. Reporting peaked in 2023 at $14,000 and has fallen 99.9% since, to $17 in 2024.

$24,085in general payments, 2019–2025

Across 7 payments — averaging $3440.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • USWM, LLC$14K
  • Y-mabs Therapeutics, Inc.$10K
  • United Therapeutics Corporation$17
$14,159,075in research payments, 2019–2025

Across 192 payments — averaging $73,745 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$8.5M
  • Ipsen Biopharmaceuticals, Inc$5.1M
  • AbbVie$483K
  • Novartis$68K
  • Jazz Pharmaceuticals Inc.$57K

What the payments were for

  • Consulting fees$10,06842%
  • Speaking & faculty fees$14,00058%
  • Food & beverage$170%

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$24,085 in reported general payments places this provider in the 80th percentile of 113 pediatric hematology-oncology providers in Tennessee.

See all pediatric hematology-oncology providers in Tennessee

Other pediatric hematology-oncology in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →